Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $135.24 million. The enterprise value is $106.83 million.

Market Cap	135.24M
Enterprise Value	106.83M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

CRDL has 69.00 million shares outstanding. The number of shares has increased by 4.94% in one year.

Shares Outstanding	69.00M
Shares Change (YoY)	+4.94%
Shares Change (QoQ)	+3.22%
Owned by Insiders (%)	4.63%
Owned by Institutions (%)	12.87%
Float	65.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.01.

Current Ratio	2.81
Quick Ratio	2.65
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.10% and return on invested capital (ROIC) is -150.32%.

Return on Equity (ROE)	-99.10%
Return on Assets (ROA)	-76.50%
Return on Capital (ROIC)	-150.32%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +118.97% in the last 52 weeks. The beta is 0.63, so CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+118.97%
50-Day Moving Average	2.20
200-Day Moving Average	1.42
Relative Strength Index (RSI)	41.46
Average Volume (20 Days)	847,428

Short Selling Information

The latest short interest is 776,285, so 1.13% of the outstanding shares have been sold short.

Short Interest	776,285
Short Previous Month	374,019
Short % of Shares Out	1.13%
Short % of Float	1.18%
Short Ratio (days to cover)	1.13

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.40M
Pretax Income	-30.22M
Net Income	-30.22M
EBITDA	-29.97M
EBIT	-30.22M
Earnings Per Share (EPS)	-$0.47

Full Income Statement

Balance Sheet

The company has $28.57 million in cash and $167,136 in debt, giving a net cash position of $28.41 million or $0.41 per share.

Cash & Cash Equivalents	28.57M
Total Debt	167,136
Net Cash	28.41M
Net Cash Per Share	$0.41
Equity (Book Value)	20.06M
Book Value Per Share	0.29
Working Capital	19.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.16 million and capital expenditures -$23,634, giving a free cash flow of -$22.18 million.

Operating Cash Flow	-22.16M
Capital Expenditures	-23,634
Free Cash Flow	-22.18M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.94%
Shareholder Yield	-4.94%
Earnings Yield	-22.34%
FCF Yield	-16.40%

Analyst Forecast

The average price target for CRDL is $7.50, which is 282.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	282.65%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1